Trial · NCT01335997
Adverse events88
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 88
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Pruritus | Skin and subcutaneous tissue disorders | Seq 1 (Periods I+II): ERN/LRPT/SIMVA → ERN/LRPT+SIMVA | 39 | 567 | 43 |
| other | Pruritus | Skin and subcutaneous tissue disorders | Seq 2 (Periods I+II): ERN/LRPT+SIM → ERN/LRPT/SIM | 29 | 554 | 33 |
| other | Pruritus | Skin and subcutaneous tissue disorders | Seq 1 (Period III): ERN/LRPT/SIMVA → ERN/LRPT+SIMVA | 0 | 83 | 0 |
| other | Pruritus | Skin and subcutaneous tissue disorders | Seq 2 (Period III): ERN/LRPT+SIM → ERN/LRPT/SIM | 0 | 82 | 0 |
| other | Flushing | Vascular disorders | Seq 1 (Periods I+II): ERN/LRPT/SIMVA → ERN/LRPT+SIMVA | 78 | 567 | 90 |
| other | Flushing | Vascular disorders | Seq 2 (Periods I+II): ERN/LRPT+SIM → ERN/LRPT/SIM | 72 | 554 | 78 |
| other | Flushing | Vascular disorders | Seq 1 (Period III): ERN/LRPT/SIMVA → ERN/LRPT+SIMVA | 0 | 83 | 0 |
| other | Flushing | Vascular disorders | Seq 2 (Period III): ERN/LRPT+SIM → ERN/LRPT/SIM | 0 | 82 | 0 |
| serious | Angina pectoris | Cardiac disorders | Seq 1 (Periods I+II): ERN/LRPT/SIMVA → ERN/LRPT+SIMVA | 1 | 567 | 1 |
| serious | Angina pectoris | Cardiac disorders | Seq 2 (Periods I+II): ERN/LRPT+SIM → ERN/LRPT/SIM | 0 | 554 | 0 |
| serious | Angina pectoris | Cardiac disorders | Seq 1 (Period III): ERN/LRPT/SIMVA → ERN/LRPT+SIMVA | 0 | 83 | 0 |
| serious | Angina pectoris | Cardiac disorders | Seq 2 (Period III): ERN/LRPT+SIM → ERN/LRPT/SIM | 0 | 82 | 0 |
| serious | Arteriospasm coronary | Cardiac disorders | Seq 1 (Periods I+II): ERN/LRPT/SIMVA → ERN/LRPT+SIMVA | 0 | 567 | 0 |
| serious | Arteriospasm coronary | Cardiac disorders | Seq 2 (Periods I+II): ERN/LRPT+SIM → ERN/LRPT/SIM | 1 | 554 | 1 |
| serious | Arteriospasm coronary | Cardiac disorders | Seq 1 (Period III): ERN/LRPT/SIMVA → ERN/LRPT+SIMVA | 0 | 83 | 0 |
| serious | Arteriospasm coronary | Cardiac disorders | Seq 2 (Period III): ERN/LRPT+SIM → ERN/LRPT/SIM | 0 | 82 | 0 |
| serious | Coronary artery disease | Cardiac disorders | Seq 1 (Periods I+II): ERN/LRPT/SIMVA → ERN/LRPT+SIMVA | 0 | 567 | 0 |
| serious | Coronary artery disease | Cardiac disorders | Seq 2 (Periods I+II): ERN/LRPT+SIM → ERN/LRPT/SIM | 1 | 554 | 1 |
| serious | Coronary artery disease | Cardiac disorders | Seq 1 (Period III): ERN/LRPT/SIMVA → ERN/LRPT+SIMVA | 0 | 83 | 0 |
| serious | Coronary artery disease | Cardiac disorders | Seq 2 (Period III): ERN/LRPT+SIM → ERN/LRPT/SIM | 0 | 82 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01335997/events